Evidence map›Paper›PMID 28396109›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2017

Association of Unilateral Renal Agenesis With Adverse Outcomes in Pregnancy: A Matched Cohort Study.

Jessica Kendrick, John Holmen, Zhiying You, Gerard Smits, Michel Chonchol

Open access · greenAbstract read
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Risk stratification for children with a solitary functioning kidney.Pediatric nephrology (Berlin, Germany) · 2021
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jessica KendrickDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO; Denver Health Medical Center, Denver, CO. Electronic address: jessica.kendrick@ucdenver.edu.
John HolmenIntermountain Healthcare, Salt Lake City, UT.
Zhiying YouDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO.
Gerard SmitsDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO.
Michel ChoncholDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO.
University of Colorado Denver · USIntermountain Healthcare · US

Funding

Vitamin D and Clinical Outcomes in Chronic Hemodialysis PatientsR01DK081473 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI CHONCHOL, MICHEL BENJAMIN · 2009 to 2012
$1.4M
Vitamin D and Arterial Function in Patients with Chronic Kidney DiseaseK23DK087859 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI KENDRICK, JESSICA B · 2011 to 2015
$784k
Bicarbonate Administration in CKDR56HL132868 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI KENDRICK, JESSICA B · 2016 to 2016
$448k
NHLBI NIH HHS R56 HL132868NIDDK NIH HHS K23 DK087859NIDDK NIH HHS R01 DK081473
6 · The paper itself

Abstract

backgroundData regarding the effect of a solitary kidney during pregnancy have come from studies of living kidney donors. We evaluated the risk for adverse pregnancy outcomes in women with a single kidney from renal agenesis. STUDY

designMatched cohort study. SETTING &

participantsUsing data from 7,079 childbirths from an integrated health care delivery system from 1996 through 2015, we identified births from women with renal agenesis. Only first pregnancies and singleton births were included. After excluding those with diabetes and kidney disease, 200 women with renal agenesis were matched 1:4 by age (within 2 years), race, and history of hypertension to women with 2 kidneys. PREDICTOR: Renal agenesis defined by International Classification of Diseases, Ninth Revision (ICD-9) codes prior to pregnancy. OUTCOMES: The primary outcome was adverse maternal outcomes, including preterm delivery, delivery by cesarean section, preeclampsia/eclampsia, and hospital length of stay. Adverse neonatal end points were considered as a secondary outcome and included low birth weight (<2,500g) and infant death/transfer to acute inpatient facility.

resultsMean gestational age at delivery was 37.9±2.1 weeks for women with renal agenesis compared to 38.6±1.8 weeks for women with 2 kidneys. Compared with women with 2 kidneys, those with renal agenesis had increased risk for preterm delivery (OR, 2.88; 95% CI, 1.86-4.45), delivery by cesarean section (OR, 2.11; 95% CI, 1.49-2.99), preeclampsia/eclampsia (OR, 2.41; 95% CI, 1.23-4.72), and length of stay longer than 3 days (OR, 1.81; 95% CI, 1.18-2.78). Renal agenesis was not significantly associated with increased risk for infant death/transfer to acute facility (OR, 2.60; 95% CI, 0.57-11.89) or low birth weight after accounting for preterm delivery (OR, 2.11; 95% CI, 0.76-5.88). LIMITATIONS: Renal agenesis was identified by ICD-9 code, not by imaging of the abdomen.

conclusionWomen with unilateral renal agenesis have a higher risk for adverse outcomes in pregnancy.

Indexed as

AdultCohort StudiesCongenital AbnormalitiesFemaleHumansInfant, NewbornKidneyKidney DiseasesPregnancyPregnancy ComplicationsPregnancy OutcomePremature BirthPrevalenceRisk Assessmentadverse maternal outcomeadverse neonatal outcomecesarean deliveryeclampsiagestational agehospital length of staylow birth weightpreeclampsiapregnancypregnancy complicationspreterm deliverySolitary kidneyunilateral renal agenesis

Identifiers

PMID28396109
PMCPMC5610923
OpenAlexW2604397541

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.